BioRestorative Therapies ... (BRTX)
NASDAQ: BRTX
· Real-Time Price · USD
1.51
0.01 (0.65%)
At close: Aug 15, 2025, 3:50 PM
1.52
0.66%
After-hours: Aug 15, 2025, 04:00 PM EDT
BioRestorative Therapies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 605.2K | 391K | 401K | 377K | 174.1K | 149.5K | 145.8K | 130.2K | 128.5K | 135.1K | 119.8K | 121.1K | 100.1K | 44K | 46K | 58K | 65K | 69K |
Cost of Revenue | 33.22K | 30.98K | 70.78K | 110.16K | 76.04K | 140.09K | 165.74K | 227.9K | 304.02K | 294.01K | 280.67K | 226.34K | 166.11K | 105.58K | 50.56K | n/a | n/a | n/a |
Gross Profit | 571.98K | 360.02K | 330.21K | 266.84K | 82.18K | -6.46K | -35.81K | -113.58K | -175.52K | -158.91K | -160.87K | -105.24K | -66.01K | -61.58K | -4.56K | 58K | 65K | 69K |
Operating Income | -13.09M | -12.25M | -11.56M | -12.09M | -12.9M | -13.55M | -15.22M | -16.68M | -18.19M | -19.7M | -18.97M | -18.3M | -17.38M | -16.31M | -26.31M | -23.15M | -20.07M | -16.98M |
Interest Income | 451.42K | 553.45K | 616.08K | 873.31K | 776.43K | 696.67K | 552.29K | 292.19K | 230.52K | 134.33K | 116.11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -10.72M | -12.1M | -8.98M | -6.17M | -310.99K | 737.02K | -2.72M | -8.24M | -17.67M | -19.36M | -18.49M | -34.55M | -34.08M | -33.47M | -44.3M | -29.66M | -26.31M | -19.38M |
Net Income | -10.72M | -12.1M | -8.98M | -6.17M | -310.99K | 737.02K | -2.65M | -7.64M | -17.11M | -18.85M | -17.82M | -34.41M | -33.89M | -33.23M | -44.3M | -29.66M | -26.31M | -19.38M |
Selling & General & Admin | 6.74M | 6.63M | 6.56M | 8M | 9.14M | 10.1M | 11.35M | 12.85M | 14.17M | 15.59M | 15.58M | 15.42M | 15.23M | 15.01M | 25.62M | 22.47M | 19.38M | 16.19M |
Research & Development | 6.92M | 5.98M | 5.33M | 4.35M | 3.84M | 3.52M | 3.97M | 3.96M | 4.14M | 4.25M | 3.51M | 3.01M | 2.25M | 1.34M | 729.06K | 741.47K | 755.1K | 855.75K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 39.81K | 116.47K | 22.61K | 5.32K | 962.00 | -92.35K | 76.5K | 93.79K | 59.99K | 85.03K | 10.04K | 10.04K | 8.39K |
Operating Expenses | 13.66M | 12.61M | 11.89M | 12.35M | 12.99M | 13.62M | 15.32M | 16.72M | 18.22M | 19.74M | 18.98M | 18.41M | 17.46M | 16.33M | 26.35M | 23.21M | 20.14M | 17.05M |
Interest Expense | n/a | n/a | n/a | 176.07K | 176.07K | 176.07K | 176.07K | n/a | 28.84K | 75.45K | 104.47K | 318.28K | 784.98K | 1.25M | 1.82M | 1.83M | 1.38M | 893.14K |
Selling & Marketing Expenses | 173.06K | 173.06K | 130.35K | -43.42K | -43.42K | -43.42K | -706 | n/a | n/a | 245.00 | 714.00 | 3.88K | 4.18K | 10.16K | 12.29K | 9.12K | 8.97K | 8.87K |
Cost & Expenses | 13.7M | 12.64M | 11.96M | 12.46M | 13.08M | 13.7M | 15.37M | 16.72M | 18.22M | 19.74M | 18.98M | 18.41M | 17.46M | 16.33M | 26.35M | 23.21M | 20.14M | 17.05M |
Income Tax Expense | n/a | n/a | -3 | -6 | -6 | -6 | -76.66K | -602.04K | -555.92K | -509.3K | -670.29K | -144.91K | -220.04K | -266.65K | -33.85K | -33.85K | -4.83K | 19.33K |
Shares Outstanding (Basic) | 8.74M | 8.36M | 7.76M | 8.12M | 8.12M | 6.67M | 4.71M | 4.57M | 3.89M | 3.72M | 3.67M | 3.64M | 3.64M | 3.52M | 872.21K | 838.69K | 795.88K | 793.98K |
Shares Outstanding (Diluted) | 8.74M | 8.36M | 7.76M | 8.12M | 8.12M | 6.67M | 4.71M | 4.57M | 3.89M | 3.72M | 3.67M | 3.64M | 3.64M | 3.52M | 872.21K | 872.21K | 836.94K | 793.98K |
EPS (Basic) | -1.28 | -1.48 | -1.17 | -0.71 | 0.46 | 0.19 | -0.99 | -2.28 | -4.61 | -5.14 | -4.93 | -27.28 | -30.98 | -34.78 | -53.2 | -37.07 | -34.18 | -21.87 |
EPS (Diluted) | -1.28 | -1.48 | -1.17 | -0.71 | 0.46 | 0.19 | -0.99 | -2.28 | -4.61 | -5.14 | -4.93 | -27.28 | -30.79 | -34.34 | -52.76 | -36.63 | -33.93 | -21.87 |
EBITDA | -12.99M | -12.11M | -11.37M | -11.9M | -7.92M | -8.58M | -10.25M | -11.88M | -18.2M | -19.72M | -19.01M | -34.34M | -33.43M | -32.37M | -42.37M | -27.76M | -24.85M | -21.75M |
EBIT | -12.44M | -12.25M | -11.56M | -12.09M | -5.03M | -5.68M | -7.35M | -8.95M | -18.33M | -19.84M | -19.11M | -34.48M | -33.56M | -32.49M | -42.49M | -27.83M | -24.94M | -18.48M |
Depreciation & Amortization | 150.42K | 198.12K | 189.06K | 181.4K | 175.28K | 198.11K | 223.76K | 285.93K | 304.02K | 294.01K | 280.67K | 226.34K | 216.7K | 231.19K | 205.21K | 180.11K | 154.99K | 106.66K |